Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Nov;6(11):596-611.
doi: 10.1038/nrurol.2009.201.

The bladder extracellular matrix. Part I: architecture, development and disease

Affiliations
Review

The bladder extracellular matrix. Part I: architecture, development and disease

Karen J Aitken et al. Nat Rev Urol. 2009 Nov.

Abstract

From the earliest studies with epithelial cells implanted into detrusor muscle to later experiments on smooth muscle in defined collagen gels, cell niche and extracellular matrix (ECM) have been clearly shown to orchestrate cellular behavior and fate whether quiescent, migratory, or proliferative. Normal matrix can revert transformed cells to quiescence, and damaged matrix can trigger malignancy or dedifferentiation. ECM influence in disease, development, healing and regeneration has been demonstrated in many other fields of study, but a thorough examination of the roles of ECM in bladder cell activity has not yet been undertaken. Structural ECM proteins, in concert with adhesive proteins, provide crucial structural support to the bladder. Both structural and nonstructural components of the bladder have major effects on smooth muscle function, through effects on matrix rigidity and signaling through ECM receptors. While many ECM components and receptors identified in the bladder have specific known functions in the vascular smooth musculature, their function in the bladder is often less well defined. In cancer and obstructive disease, the ECM has a critical role in pathogenesis. The challenge in these settings will be to find therapies that prevent hyperproliferation and encourage proper differentiation, through an understanding of matrix effects on cell biology and susceptibility to therapeutics.

PubMed Disclaimer

References

    1. Am J Physiol Heart Circ Physiol. 2001 Mar;280(3):H1354-60 - PubMed
    1. Proc Natl Acad Sci U S A. 1997 Mar 4;94(5):1852-6 - PubMed
    1. Cardiovasc Hematol Agents Med Chem. 2007 Apr;5(2):109-32 - PubMed
    1. J Pediatr Surg. 2004 Feb;39(2):170-3; discussion 170-3 - PubMed
    1. BJU Int. 2003 Jan;91(1):89-93 - PubMed

MeSH terms